Anti-CD93 antibody [EPR5386]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(12 Publications)
Rabbit Recombinant Monoclonal CD93 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human, Rat samples. Cited in 12 publications.
View Alternative Names
CD93, C1QR1, MXRA4, Complement component C1q receptor, C1q/MBL/SPA receptor, CDw93, Complement component 1 q subcomponent receptor 1, Matrix-remodeling-associated protein 4, C1qR, C1qR(p), C1qRp
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CD93 antibody [EPR5386] (AB134079)
Intracellular flow cytometric analysis of permeabilized THP-1 cells labelling CD93 red with ab134079 at 1/100 and a rabbit IgG negative (green).
- WB
Unknown
Western blot - Anti-CD93 antibody [EPR5386] (AB134079)
All lanes:
Western blot - Anti-CD93 antibody [EPR5386] (ab134079) at 1/1000 dilution
Lane 1:
THP-1 lysate at 10 µg
Lane 2:
Rat kidney lysate at 10 µg
Lane 3:
Human platelet lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti-rabbit at 1/2000 dilution
Predicted band size: 69 kDa
Observed band size: 120 kDa
false
- WB
Lab
Western blot - Anti-CD93 antibody [EPR5386] (AB134079)
The expression profile observed in Raji and 293T is consistent with the literatures (PMID : 31182688, PMID : 15459234).
Negative control : Raji and 293T (PMID : 31182688, PMID : 15459234).
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CD93 antibody [EPR5386] (ab134079) at 1/1000 dilution
Lane 1:
U937 (human histiocytic lymphoma monocyte) whole cell lysate at 20 µg
Lane 2:
Raji (human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 3:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 4:
Rat spleen tissue lysate at 20 µg
Lane 5:
Mouse spleen tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 100 kDa,50-80 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-CD93 antibody [EPR5386] (AB134079)
Bands around 100kDa and 75kDa are full length CD93 with different level of glycosylation (PMID : 19603257). We are not sure the identity of bands below 70kDa.
The expression profile observed in Raji and 293T is consistent with the literatures (PMID : 31182688, PMID : 15459234).
Negative control : Raji and 293T (PMID : 31182688, PMID : 15459234).
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CD93 antibody [EPR5386] (ab134079) at 1/1000 dilution
Lane 1:
U937 (human histiocytic lymphoma monocyte) whole cell lysate at 20 µg
Lane 2:
Raji (human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 3:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 4:
Rat spleen tissue lysate at 20 µg
Lane 5:
Mouse spleen tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 69 kDa
Observed band size: 100 kDa,50-80 kDa
false
Exposure time: 180s
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CD93 antibody [EPR5386] (AB134079)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (8)
-
Anti-CD93 antibody [EPR5386] - BSA and Azide free
-
578 PE
PE Anti-CD93 antibody [EPR5386]
-
660 APC
APC Anti-CD93 antibody [EPR5386]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD93 antibody [EPR5386]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD93 antibody [EPR5386]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD93 antibody [EPR5386]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-CD93 antibody [EPR5386]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD93 antibody [EPR5386]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD93 contributes to cellular processes through its role in the clearance of apoptotic cells and immune surveillance. It also partakes in angiogenesis facilitating the growth of new blood vessels. CD93 often functions as part of a larger complex in binding with other molecules to support cellular communication. By modulating the immune response CD93 ensures efficient removal of cellular debris maintaining homeostasis and preventing autoimmune reactions.
Pathways
CD93 operates within the innate immune response and complement system pathways. It closely interacts with other proteins such as C1q which is part of the complement activation pathway. This interaction supports the clearance of immune complexes and cellular debris. By facilitating these processes CD93 aids in maintaining the balance between immune activation and tolerance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:21768 PubMed40596517
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular neurodegeneration 19:95 PubMed39695808
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:13329 PubMed38858476
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23688 PubMed38511888
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:5724 PubMed38459174
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 42:4958-4979 PubMed35606143
2022
Applications
Unspecified application
Species
Unspecified reactive species
Kidney international 101:137-143 PubMed34619231
2021
Applications
mIHC
Species
Human
STAR protocols 2:100747 PubMed34430920
2021
Applications
mIHC
Species
Human
Cell reports 34:108663 PubMed33503440
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 18:6413-6422 PubMed31819775
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com